AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank93
3Y CAGR+23.2%
5Y CAGR+0.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+23.2%/yr
vs -8.0%/yr prior
5Y CAGR
+0.8%/yr
Recent acceleration
Acceleration
+31.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.14B | +17.3% |
| 2024 | $11.20B | -41.4% |
| 2023 | $19.11B | +172.2% |
| 2022 | $7.02B | +35.7% |
| 2021 | $5.17B | -59.0% |
| 2020 | $12.61B | +15.7% |
| 2019 | $10.90B | +11.1% |
| 2018 | $9.81B | +26.0% |
| 2017 | $7.78B | +8.9% |
| 2016 | $7.15B | - |